急性脑损伤患者的肌酐清除率:方法学比较
这项前瞻性、观察性、单中心研究纳入74例因颅脑创伤或蛛网膜下腔出血入住神经重症ICU的患者,比较实测肌酐清除率(MCC)与Cockcroft-Gault(CG)、MDRD、CKD-EPI公式估计值,并评估Augmented renal clearance(ARC,CrCl>130 ml/min/1.73 m2)的发生率。结果显示MCC与三种公式估计值之间均为弱相关,MCC与MDRD相关性最强、与CKD-EPI最弱,Bland-Altman图显示各对差异在临床上不可接受。按MCC计算,78%的测量存在ARC。当MCC≤130 ml/min/1.73 m2时三种公式高估MCC,当MCC>130 ml/min/1.73 m2时三种公式低估MCC。作者认为在此类患者中或应优先采用实测肌酐清除率评估肾功能,以更好地调整药物剂量并保证药物疗效。
要点
- 74例重型颅脑创伤或蛛网膜下腔出血患者中,按实测肌酐清除率(MCC)计算,78%的测量存在ARC(CrCl>130 ml/min/1.73 m2)。
- MCC与CG、MDRD、CKD-EPI三种公式估计值之间均为弱相关,其中MCC与MDRD相关性最强、与CKD-EPI最弱。
- Bland-Altman图显示MCC与三种公式估计值之间的差异在临床上不可接受。
- 当MCC≤130 ml/min/1.73 m2时CG、MDRD、CKD-EPI均高估MCC,当MCC>130 ml/min/1.73 m2时三种公式均低估MCC。
- 作者认为在临床中或应优先采用实测肌酐清除率评估肾功能,以更好地调整药物剂量并保证药物疗效。
适用人群与场景
- 因颅脑创伤或蛛网膜下腔出血入住神经重症ICU的成人患者,共74例,中位年龄53岁(IQR 36-65),入院中位GCS评分6分。
诊断标准与关键阈值
- Augmented renal clearance(ARC)定义为肌酐清除率(CrCl)>130 ml/min/1.73 m2。
- 实测肌酐清除率(MCC)采用上午7时血清肌酐和6小时尿液收集计算。
- 估计肌酐清除率分别采用Cockcroft-Gault公式(CG)、Modification of Diet in Renal Disease Study方程(MDRD)和Chronic Kidney Disease Epidemiology Collaboration公式(CKD-EPI)。
研究设计与关键结果
- 研究类型为前瞻性、观察性、单中心研究,纳入74例因颅脑创伤或蛛网膜下腔出血入住神经重症ICU的患者。
- 入院时MCC中位数为176 ml/min/1.73 m2(IQR 135-214);CG中位数为129 ml/min/1.73 m2(IQR 95-176),MDRD中位数为158 ml/min/1.73 m2(IQR 115-202),CKD-EPI中位数为116 ml/min/1.73 m2(IQR 97-132)。
- MCC与三种公式估计的CrCl之间均为弱相关;ICC统计相关性在MCC与MDRD之间最强,在MCC与CKD-EPI之间最弱。
- Bland-Altman图显示各对之间的差异在临床上不可接受。
- 按MCC计算,78%的测量存在ARC。
- 当MCC≤130 ml/min/1.73 m2时,CG、MDRD和CKD-EPI均高估MCC;当MCC>130 ml/min/1.73 m2时,三种公式均低估MCC。
证据类型、等级与局限
- 证据类型:前瞻性、观察性、单中心研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在临床中或应优先采用实测肌酐清除率评估肾功能,以更好地调整药物剂量并保证药物疗效。
- 在MCC>130 ml/min/1.73 m2的ARC患者中,CG、MDRD和CKD-EPI公式均低估MCC,可能影响经肾清除药物的剂量调整。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Currently, the measurement of glomerular filtration rate is very complex and costly, so its daily evaluation is performed using endogenous markers, of which creatinine is the most frequently used. It allows the estimation of glomerular filtration rate by means of its clearance or by formulas based on its serum and urine concentration. Augmented renal clearance (ARC) is frequent among critically ill patients and is defined as creatinine clearance (CrCl) > 130 ml/min/1.73 m2. The aim of this study was to compare measured CrCl (MCC) and estimated CrCl obtained with the Cockcroft-Gault formula (CG), the Modification of Diet in Renal Disease Study equation (MDRD), and the Chronic Kidney Disease Epidemiology Collaboration formula (CKD-EPI) in patients with severe traumatic brain injury and nontraumatic subarachnoid hemorrhage. The second aim was to assess the incidence of ARC in this population of neurocritical patients.
METHODS: This was a prospective, observational, single center study from a cohort of 74 patients admitted to the neurocritical intensive care unit due to traumatic brain injury or subarachnoid hemorrhage. Serum creatinine (at 7 a.m.) and a 6-h urine collection were analyzed, and CrCl was measured and estimated by using CG, MDRD, and CKD-EPI. The intraclass correlation coefficient (ICC) was evaluated for each pair, and Bland-Altman plots were used to assess clinical significance.
RESULTS: Among 74 patients, the median age was 53 (interquartile range [IQR] 36-65), and the median Glasgow Coma Scale score at admission was 6. The median MCC at admission was 176 (IQR 135-214). The medians of CG, MDRD and CKD-EPI were, respectively, 129 ml/min/1.73 m2 (IQR 95-176), 158 (IQR 115-202), and 116 (97-132). An ICC was applied to evaluate the correlation between MCC and estimated methods and showed a weak correlation between MCC and estimated CrCl obtained with the three different methods. The strongest ICC statistical correlation was found between MCC and MDRD, and the weakest correlation was found between MCC and CKD-EPI. Bland-Altman plots showed that differences between each pair were not clinically acceptable. ARC was present in 78% of measurements, using MCC. A weak correlation was observed between MCC and calculated CrCl. CG, MDRD, and CKD-EPI overestimated MCC when MCC ≤ 130 ml/min/1.73 m2 and underestimated it when MCC > 130 ml/min/1.73 m2.
CONCLUSIONS: In this population, there was a weak statistical correlation between measured and estimated methods. In patients with ARC, formulas underestimated MCC. MCC should probably be the preferred methodology for renal function assessment in the clinical setting to better adjust drug dosage and guarantee drug effectiveness.
参考来源
- Monteiro E, Fraga Pereira M, Barroso I, et al. Creatinine Clearance in Acute Brain Injury: A Comparison of Methods. Neurocrit Care. 2023. PMID: 37016059. doi:10.1007/s12028-023-01714-4
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。